Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
出版年份 2018 全文链接
标题
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 3, Pages 768
出版商
MDPI AG
发表日期
2018-03-08
DOI
10.3390/ijms19030768
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists
- (2018) Hiroki Mitoma et al. CYTOKINE
- Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases
- (2017) Jee Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Infliximab crystal structures reveal insights into self-association
- (2017) Thomas F. Lerch et al. mAbs
- Higher order structures of Adalimumab, Infliximab and their complexes with TNFα revealed by electron microscopy
- (2017) Bich Ngoc Tran et al. PROTEIN SCIENCE
- Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases
- (2016) Emma D. Deeks BIODRUGS
- Simple NMR methods for evaluating higher order structures of monoclonal antibody therapeutics with quinary structure
- (2016) Kang Chen et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Effects of Protein Conformation, Apparent Solubility, and Protein–Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody
- (2016) Cavan Kalonia et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Acid-induced aggregation propensity of nivolumab is dependent on the Fc
- (2016) Boning Liu et al. mAbs
- Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
- (2016) Karin A. van Schie et al. Scientific Reports
- State of the art paper Tumor necrosis factor inhibitors – state of knowledge
- (2015) Krzysztof Lis et al. Archives of Medical Science
- Pegylation of Biological Molecules and Potential Benefits: Pharmacological Properties of Certolizumab Pegol
- (2014) Gianfranco Pasut BIODRUGS
- Intravenous golimumab in rheumatoid arthritis
- (2014) Marc D Cohen et al. Expert Review of Clinical Immunology
- Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
- (2014) David J. Shealy et al. mAbs
- Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
- (2013) Clara De Simone et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- The Cytotoxic Effects of Certolizumab Pegol and Golimumab Mediated by Transmembrane Tumor Necrosis Factor α
- (2013) Naoyasu Ueda et al. INFLAMMATORY BOWEL DISEASES
- Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View
- (2013) Shi Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab
- (2013) Shuaiyi Liang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes
- (2013) Constanze Buhrmann et al. ARTHRITIS RESEARCH & THERAPY
- mTNF reverse signalling induced by TNFα antagonists involves a GDF-1 dependent pathway: implications for Crohn's disease
- (2012) Stefanie Derer et al. GUT
- Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab
- (2012) Kacper A. Wojtal et al. PLoS One
- Origin and evolution of TNF and TNF receptor superfamilies
- (2011) Gregory D. Wiens et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Update upon efficacy and safety of TNF-α inhibitors
- (2011) Giuseppe Murdaca et al. Expert Opinion On Drug Safety
- Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases
- (2010) Peter C Taylor CURRENT OPINION IN PHARMACOLOGY
- Lymphotoxin α stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblasts
- (2010) Flavia Calmon-Hamaty et al. CYTOKINE
- Anti–Tumor Necrosis Factor-α Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
- (2010) Anne Christine W. Vos et al. GASTROENTEROLOGY
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Solution of the Structure of the TNF-TNFR2 Complex
- (2010) Y. Mukai et al. Science Signaling
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Certolizumab pegol for the management of Crohn's disease in adults
- (2009) Anastasia Rivkin CLINICAL THERAPEUTICS
- Differences in binding and effector functions between classes of TNF antagonists
- (2009) Taruna Arora et al. CYTOKINE
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumab
- (2008) Hiroki Mitoma et al. ARTHRITIS AND RHEUMATISM
- A PEGylated Fab′ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease
- (2008) Tim Bourne et al. BIODRUGS
- Etanercept
- (2008) Erin Ducharme et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
- (2007) Daniel Tracey et al. PHARMACOLOGY & THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started